--2025/Q1-- / 69.300M--
--2024/Q4-- / 77.957M--
--2024/Q359.879M / 68.175M--
Aug 8, 20242024/Q265.389M / 66.290M--
May 9, 20242024/Q151.936M / 56.658M--
MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
RVNC Revance Therapeutics
- 3.090
- +0.030+0.98%
Close Jan 3 16:00 ET
- 3.090
- 0.0000.00%
Post 19:54 ET
322.56MMarket Cap-1.61P/E (TTM)
3.090High3.050Low1.27MVolume3.050Open3.060Pre Close3.92MTurnover1.33%Turnover RatioLossP/E (Static)104.39MShares7.58752wk High-1.98P/B296.43MFloat Cap2.30052wk Low--Dividend TTM95.93MShs Float42.410Historical High--Div YieldTTM1.31%Amplitude2.300Historical Low3.080Avg Price1Lot Size
Revance Therapeutics Key Stats
Revance Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Revance Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data